Related references
Note: Only part of the references are listed.Off-label targeted therapy (TT) use in recurrent/metastatic NSCLC.
Victoria Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Exhaled Breath Condensate-A Non-Invasive Approach for Diagnostic Methods in Asthma
Joanna Polomska et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
S. S. Ramalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Small lung tumor biopsy samples are feasible for high quality targeted next generation sequencing
Hidenori Kage et al.
CANCER SCIENCE (2019)
Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
Edward B. Garon et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
Y. -L. Wu et al.
ANNALS OF ONCOLOGY (2019)
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
Yuebi Hu et al.
CLINICAL CANCER RESEARCH (2018)
Brief Report on the Detection of the EGFR T790M Mutation in Exhaled Breath Condensate from Lung Cancer Patients
Robert J. Smyth et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection
Christopher Abbosh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
David Tamborero et al.
GENOME MEDICINE (2018)
Targeted Therapy and Immune Therapy for Small Cell Lung Cancer
Shirish M. Gadgeel
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Routine molecular screening of advanced refractory cancer patients: An analysis of the first 2490 patients of the ProfiLER study
Olivier Tredan et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Genomic Profile of Cell-Free DNA from Sputum, Plasma, Urine and Tumor Tissue and Correlation with Clinical Effect in Advanced NSCLC
Z. Wu et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Non-blood circulating tumor DNA detection in cancer
Muyun Peng et al.
ONCOTARGET (2017)
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS)
Hussam Al-Kateb et al.
MOLECULAR ONCOLOGY (2015)
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Clinical Next-Generation Sequencing in Patients with Non-Small Cell Lung Cancer
Ian S. Hagemann et al.
CANCER (2015)
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Mark G. Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics
Rashmi Kanagal-Shamanna et al.
MODERN PATHOLOGY (2014)
Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene
Jacek Kordiak et al.
RESPIRATORY MEDICINE (2012)
Lung Cancer: Epidemiology, Etiology, and Prevention
Charles S. Dela Cruz et al.
CLINICS IN CHEST MEDICINE (2011)
Share Paper
